Title : Activating mutations of c-kit at codon 816 confer drug resistance in human leukemia cells.

Pub. Date : 2001 May

PMID : 11378569






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We have identified activating mutations of c-kit at codon 816 (Asp(816) ) from a revertant of the cytokine-dependent acute myeloid leukemia (AML) cell line, MO7e (D816H), and de novo childhood AML (D816N). Aspartic Acid KIT proto-oncogene, receptor tyrosine kinase Homo sapiens
2 These results suggest a potentially important role of Asp(816) mutations of c-kit in both malignant cell proliferation and resistance to therapy. Aspartic Acid KIT proto-oncogene, receptor tyrosine kinase Homo sapiens